Intracardiac atrial defibrillation

Heart Rhythm

Volumn 4, Issue 3 SUPPL., 2007, Pages

  Dosdall, Derek J ^a   Ideker, Raymond E ^a,b,c  

^a and Radiation Oncology   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Internal atrial defibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; FLECAINIDE; IBUTILIDE; MIDAZOLAM; MORPHINE SULFATE; PROCAINAMIDE;

ARTICLE; CORONARY SINUS; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; ELECTRIC SHOCK; ELECTRODE; ELIXIR; HEART ATRIUM; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM; HEART RIGHT VENTRICLE; HEART VENTRICLE; HEART VENTRICLE FIBRILLATION; HUMAN; PAIN; PRIORITY JOURNAL; SEDATION; SUPERIOR CAVA VEIN; THROMBOEMBOLISM; TREATMENT OUTCOME;

ANALGESICS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; HEART CONDUCTION SYSTEM; HUMANS; HYPNOTICS AND SEDATIVES; PAIN; PAIN THRESHOLD; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 33847297650     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.12.030     Document Type: Article

References (38)

1. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., and Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001) 2370-2375
2. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., Riegel B., Priori S.G., Blanc J.J., Budaj A., Camm A.J., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., and Zamorano J.L. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e257-e354
3. Mittal S., Ayati S., Stein K.M., Schwartzman D., Cavlovich D., Tchou P.J., Markowitz S.M., Slotwiner D.J., Scheiner M.A., and Lerman B.B. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 101 (2000) 1282-1287
4. Niebauer M.J., Brewer J.E., Chung M.K., and Tchou P.J. Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter. Am J Cardiol 93 (2004) 1495-1499
5. Alatawi F., Gurevitz O., White R.D., Ammash N.M., Malouf J.F., Bruce C.J., Moon B.S., Rosales A.G., Hodge D., Hammill S.C., Gersh B.J., and Friedman P.A. Prospective, randomized comparison of two biphasic waveforms for the efficacy and safety of transthoracic biphasic cardioversion of atrial fibrillation. Heart Rhythm 2 (2005) 382-387
6. Kim M.L., Kim S.G., Park D.S., Gross J.N., Ferrick K.J., Palma E.C., and Fisher J.D. Comparison of rectilinear biphasic waveform energy versus truncated exponential biphasic waveform energy for transthoracic cardioversion of atrial fibrillation. Am J Cardiol 94 (2004) 1438-1440
7. Neal S., Ngarmukos T., Lessard D., and Rosenthal L. Comparison of the efficacy and safety of two biphasic defibrillator waveforms for the conversion of atrial fibrillation to sinus rhythm. Am J Cardiol 92 (2003) 810-814
8. Scholten M., Szili-Torok T., Klootwijk P., and Jordaens L. Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation. Heart 89 (2003) 1032-1034
9. Kirchhof P., Monnig G., Wasmer K., Heinecke A., Breithardt G., Eckardt L., and Bocker D. A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA). Eur Heart J 26 (2005) 1292-1297
10. Levy S. Internal defibrillation: where we have been and where we should be going?. J Interv Card Electrophysiol 13 Suppl 1 (2005) 61-66
11. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., Riegel B., Priori S.G., Blanc J.J., Budaj A., Camm A.J., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., and Zamorano J.L. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8 (2006) 651-745
12. Kistler P.M., Sanders P., Morton J.B., Vohra J.K., Kalman J.M., and Sparks P.B. Effect of body mass index on defibrillation thresholds for internal cardioversion in patients with atrial fibrillation. Am J Cardiol 94 (2004) 370-372
13. Boriani G., Biffi M., Camanini C., Luceri R.M., and Branzi A. Transvenous low energy internal cardioversion for atrial fibrillation: a review of clinical applications and future developments. Pacing Clin Electrophysiol 24 (2001) 99-107
14. Gasparini G., Bonso A., Themistoclakis S., Giada F., and Raviele A. Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up. Europace 3 (2001) 90-95
15. Joglar J.A., and Kowal R.C. Electrical cardioversion of atrial fibrillation. Cardiol Clin 22 (2004) 101-111
16. Kusumoto F.M. Internal atrial and ventricular defibrillation during electrophysiology procedures. J Interv Card Electrophysiol 13 Suppl 1 (2005) 71-78
17. Karch M.R., Schmieder S., Ndrepepa G., Schneider M.A., Zrenner B., and Schmitt C. Internal atrial defibrillation during electrophysiological studies and focal atrial fibrillation ablation procedures. Pacing Clin Electrophysiol 24 (2001) 1464-1469
18. Lau C.P., Tse H.F., and Ayers G.M. Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus. J Am Coll Cardiol 33 (1999) 1217-1226
19. Wellens H.J., Lau C.P., Luderitz B., Akhtar M., Waldo A.L., Camm A.J., Timmermans C., Tse H.F., Jung W., Jordaens L., and Ayers G. Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 98 (1998) 1651-1656
20. Zhou X., Daubert J.P., Wolf P.D., Smith W.M., and Ideker R.E. Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs. Circ Res 72 (1993) 145-160
21. Cooper R., and KenKnight B. The role of waveforms and lead configurations for internal atrial cardioversion. Herzschr Elektrophys 9 (1998) 76-82
22. Rashba E.J., Shorofsky S.R., Scheiner A., Peters R.W., Ma C., and Gold M.R. Coronary sinus electrode does not reduce atrial defibrillation thresholds. Heart Rhythm 3 (2006) 647-652
23. Ideker R.E., Wolf P.D., Alferness C.A., Krassowska W., and Smith W.M. Current concepts for selecting the location, size, and shape of defibrillation electrodes. Pacing Clin Electrophysiol 14 (1991) 227-240
24. Zheng X., Benser M.E., Walcott G.P., Girouard S.D., Rollins D.L., Smith W.M., and Ideker R.E. Reduction of atrial defibrillation threshold with an interatrial septal electrode. Circulation 102 (2000) 2659-2664
25. Zheng X., Benser M.E., Walcott G.P., and Ideker R.E. Right atrial septal electrode for reducing the atrial defibrillation threshold. Circulation 104 (2001) 1066-1070
26. Zheng X., Benser M.E., Walcott G.P., Smith W.M., and Ideker R.E. Reduction of the internal atrial defibrillation threshold with balanced orthogonal sequential shocks. J Cardiovasc Electrophysiol 13 (2002) 904-909
27. Cooper R.A., Plumb V.J., Epstein A.E., Kay G.N., and Ideker R.E. Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans. Circulation 97 (1998) 2527-2535
28. Benser M.E., Walcott G.P., Killingsworth C.R., Girouard S.D., Morris M.M., and Ideker R.E. Atrial defibrillation thresholds of electrode configurations available to an atrioventricular defibrillator. J Cardiovasc Electrophysiol 12 (2001) 957-964
29. Swerdlow C.D., Schwartzman D., Hoyt R., Bailin S.J., Koehler J.L., and Warman E.N. Determinants of first-shock success for atrial implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 13 (2002) 347-354
30. Tse H.F., Timmermans C., Rodriguez L.M., Lau C.P., and Wellens H.J. Effect of coronary sinus electrode on the optimal atrial defibrillation pathway for an atrioventricular defibrillator. J Cardiovasc Electrophysiol 14 (2003) 32-37
31. Marcus G.M., and Sung R.J. Antiarrhythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting maintenance of sinus rhythm. Cardiology 95 (2001) 1-8
32. Capucci A., Villani G.Q., Marrazzo N., and Piepoli M. The complimentary role of drug, ablation and device in electrical therapy of atrial fibrillation. Eur Heart J Suppl 3 (2001) P47-P52
33. Weigner M.J., Caulfield T.A., Danias P.G., Silverman D.I., and Manning W.J. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med 126 (1997) 615-620
34. Steinhaus D.M., Cardinal D.S., Mongeon L., Musley S.K., Foley L., and Corrigan S. Internal defibrillation: pain perception of low energy shocks. Pacing Clin Electrophysiol 25 (2002) 1090-1093
35. Mitchell A.R., Spurrell P.A., Gerritse B.E., and Sulke N. Improving the acceptability of the atrial defibrillator for the treatment of persistent atrial fibrillation: the atrial defibrillator sedation assessment study (ADSAS). Int J Cardiol 96 (2004) 141-145
36. Boodhoo L., Mitchell A., Ujhelyi M., and Sulke N. Improving the acceptability of the atrial defibrillator: patient-activated cardioversion versus automatic night cardioversion with and without sedation (ADSAS 2). Pacing Clin Electrophysiol 27 (2004) 910-917
37. Haffajee C.I., Chaudhry G.M., Casavant D., and Pacetti P.E. Efficacy and tolerability of automatic nighttime atrial fibrillation shocks in patients with permanent internal atrial defibrillators. Am J Cardiol 89 (2002) 875-878
38. Fabian T.J., Schwartzman D.S., Ujhelyi M.R., Corey S.E., Bigos K.L., Pollock B.G., and Kroboth P.D. Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam. J Cardiovasc Electrophysiol 17 (2006) 391-395